Welcome to the all-new Vetlearn

  • What’s new on Vetlearn?
  • The latest issues of Compendium and
    Veterinary Technician
  • New CE articles for veterinarians and technicians
  • Expert advice on practice management
  • Care guides on more than 400 subjects
    to give to your clients
  • And more!

To access Vetlearn, you must first sign in or register.

registernow

Become a Member

Reference Desk May 2012

Boehringer Ingelheim Calls for Proposals on Equine Pigeon Fever

    Researchers invited to participate in second annual Equine Research Awards

    ST. JOSEPH, Missouri, April 30, 2012—Public and private researchers studying Pigeon Fever (Corynebacterium pseudotuberculosis) are invited to submit proposals for the 2012 Equine Research Awards sponsored by Boehringer Ingelheim Vetmedica, Inc. (BIVI).

    Proposals must address one or more specific criteria to be considered:

    • Pathophysiology of Corynebacterium pseudotuberculosis and development of an equine challenge model.
    • Virulence factors and strain differences among isolates of Corynebacterium pseudotuberculosis isolated from internal and external infections and different geographic locations.
    • Increased incidence and spread to different geographic locations and association with climate change.
    • Comparison of host immunity between infections resulting in internal infection and recurrent infection in recovered horses.
    • Seasonality of infection with Corynebacterium pseudotuberculosis and studies of insect vectors.

    Veterinarians, diagnosticians and public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of Pigeon Fever. BIVI will provide three individual $25,000 awards to fund the selected research proposals.
    Proposals must be submitted by September 1, 2012, and will be reviewed by an independent Equine Research Review Board comprising industry professionals, including practicing equine veterinarians and researchers. Awards will be selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies. The awards will be announced during the 2012 American Association of Equine Practitioners Annual Convention in Anaheim, Calif.

    The BIVI Equine Research Awards were launched in 2011 to support veterinary research that results in practical applications or insights into important equine diseases and that improves the quality of life for all horses. Each year’s awards focus on one specific equine disease area. Equine Rhinitis Virus was the topic for the inaugural awards.

    To participate in the research award program, submit a proposal, cover letter, Curriculum Vitae and two letters of recommendation by September 1, 2012, to:

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    “2012 Equine Research Awards”
    5506 Corporate Dr., Suite 1600
    St. Joseph, MO 64507-7752 USA

    For more information and submission instructions, go to www.equinediseaseresearch.com.

    About Boehringer Ingelheim
    The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. For more information, visit http://us.boehringer-ingelheim.com.

    Source: Boehringer Ingelheim

    didyouknow

    Did you know... Common diseases that require isolation of infected horses and full barrier protection include salmonellosis, strangles, influenza, rotavirus infection, herpesvirus infections (particularly those caused by equine herpesvirus 1 or 4), infectious anemia, and rabies.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe